208370 — Selvas Healthcare Income Statement
0.000.00%
Last trade - 00:00
- KR₩122bn
- KR₩114bn
- KR₩30bn
- 31
- 24
- 21
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22,351 | 21,152 | 29,089 | 27,686 | 29,813 |
Cost of Revenue | |||||
Gross Profit | 8,464 | 9,758 | 13,959 | 14,118 | 15,650 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25,798 | 20,294 | 25,788 | 25,746 | 26,467 |
Operating Profit | -3,447 | 858 | 3,301 | 1,939 | 3,346 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,989 | 745 | 2,537 | 2,852 | 3,858 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,328 | 759 | 2,472 | 2,813 | 5,170 |
Net Income Before Extraordinary Items | |||||
Net Income | -3,328 | 759 | 2,472 | 2,813 | 5,170 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -3,328 | 759 | 2,472 | 2,230 | 5,170 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -235 | 52.6 | 141 | 117 | 218 |